Cargando…

Primary and secondary autoimmune neutropenia

Antineutrophil antibodies are well recognized causes of neutropenia, producing both quantitative and qualitative defects in neutrophils and increased risk for infection. In primary autoimmune neutropenia (AIN) of infancy, a moderate to severe neutropenia is the sole abnormality; it is rarely associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Capsoni, Franco, Sarzi-Puttini, Piercarlo, Zanella, Alberto
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1257445/
https://www.ncbi.nlm.nih.gov/pubmed/16207350
http://dx.doi.org/10.1186/ar1803
_version_ 1782125808067805184
author Capsoni, Franco
Sarzi-Puttini, Piercarlo
Zanella, Alberto
author_facet Capsoni, Franco
Sarzi-Puttini, Piercarlo
Zanella, Alberto
author_sort Capsoni, Franco
collection PubMed
description Antineutrophil antibodies are well recognized causes of neutropenia, producing both quantitative and qualitative defects in neutrophils and increased risk for infection. In primary autoimmune neutropenia (AIN) of infancy, a moderate to severe neutropenia is the sole abnormality; it is rarely associated with serious infections and exhibits a self-limited course. Chronic idiopathic neutropenia of adults is characterized by occurrence in late childhood or adulthood, greater prevalence among females than among males, and rare spontaneous remission. Secondary AIN is more commonly seen in adults and underlying causes include collagen disorders, drugs, viruses and lymphoproliferative disorders. In most patients with AIN, antibodies recognize antigens located on the IgG Fc receptor type 3b but other target antigens have been recently identified in secondary AIN. Granulocyte colony-stimulating factor is a proven treatment in patients with AIN of all types and is now preferred to other possible therapies.
format Text
id pubmed-1257445
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-12574452005-10-19 Primary and secondary autoimmune neutropenia Capsoni, Franco Sarzi-Puttini, Piercarlo Zanella, Alberto Arthritis Res Ther Review Antineutrophil antibodies are well recognized causes of neutropenia, producing both quantitative and qualitative defects in neutrophils and increased risk for infection. In primary autoimmune neutropenia (AIN) of infancy, a moderate to severe neutropenia is the sole abnormality; it is rarely associated with serious infections and exhibits a self-limited course. Chronic idiopathic neutropenia of adults is characterized by occurrence in late childhood or adulthood, greater prevalence among females than among males, and rare spontaneous remission. Secondary AIN is more commonly seen in adults and underlying causes include collagen disorders, drugs, viruses and lymphoproliferative disorders. In most patients with AIN, antibodies recognize antigens located on the IgG Fc receptor type 3b but other target antigens have been recently identified in secondary AIN. Granulocyte colony-stimulating factor is a proven treatment in patients with AIN of all types and is now preferred to other possible therapies. BioMed Central 2005 2005-08-31 /pmc/articles/PMC1257445/ /pubmed/16207350 http://dx.doi.org/10.1186/ar1803 Text en Copyright © 2005 BioMed Central Ltd
spellingShingle Review
Capsoni, Franco
Sarzi-Puttini, Piercarlo
Zanella, Alberto
Primary and secondary autoimmune neutropenia
title Primary and secondary autoimmune neutropenia
title_full Primary and secondary autoimmune neutropenia
title_fullStr Primary and secondary autoimmune neutropenia
title_full_unstemmed Primary and secondary autoimmune neutropenia
title_short Primary and secondary autoimmune neutropenia
title_sort primary and secondary autoimmune neutropenia
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1257445/
https://www.ncbi.nlm.nih.gov/pubmed/16207350
http://dx.doi.org/10.1186/ar1803
work_keys_str_mv AT capsonifranco primaryandsecondaryautoimmuneneutropenia
AT sarziputtinipiercarlo primaryandsecondaryautoimmuneneutropenia
AT zanellaalberto primaryandsecondaryautoimmuneneutropenia